Search results for: 'forecast+2023'

Frost and Sullivan expects 2023 to be the year of resilience. Businesses will face a range of challenges, including a global economic slowdown, supply chain bottlenecks, and geopolitical shocks. Organizations of all sizes and types will be compelled to find new areas for growth, despite an abrupt downturn in consumer demand. This study identifi...

The care coordination workflow aims to optimize the entire value chain of patient care. The objective of this research service is to present a comprehensive analysis of the US care coordination software market, with respect to market potential and key market dynamics at play in the next 5 years. The regional scope of the analysis is the United Stat...

02 Feb 2017  |  Europe  |  Market Research

European Next-generation Sequencing Services Market, Forecast to 2023

Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

Infographics

×

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-changing Compa...

The professional headset market will continue to experience notable growth rates due to the evolution of software-based communications and collaboration services and the need to improve worker productivity. The largest opportunity lies within professional headsets that offer PC USB connectivity and value-added features to optimize the software com...

14 Jan 2019  |  North America  |  Market Research

Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

Infographics

×

Key Issues Addressed

Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...

11 Jul 2019  |  North America  |  Market Research

Growth Opportunities in the Global Radiology-as-a-Service Market, Forecast to 2023

Innovative Business Models Focusing on Operational, Clinical, and Financial Excellence Witnessing Growing Adoption, Due to Increasing Influence of Value-based Care and Sustainable Healthcare Initiatives in the Imaging Ecosystem

Infographics

×

This Growth Opportunity service presents an analysis of the emerging ‘servitization’ business models in the medical imaging industry. With healthcare systems gradually transitioning to value-based care, imaging vendors across the value chain are positioning themselves as partners in this journey through risk-sharing and outcome-based services, with...

Buy now, pay later (BNPL), also referred to as point of sale (PoS) installment loans, is a short-term financing option that enables consumers to spread out payments for purchases over a period of time. The increase in eCommerce activity during the COVID-19 pandemic brought along with it a strong interest in alternative spending options. BNPL, a sub...

26 Jan 2017  |  North America  |  Megatrends

The Future of the United States

The Social and Technological Forces Reshaping the Country

Infographics

×

Frost & Sullivan's research service on The Future of the United States offers a comprehensive analysis of the Mega Trends that will impact American citizens and businesses through 2025. In this research, Frost & Sullivan's expert analysts highlight the imminent challenges and opportunities for growth stemming from the following trends: Social, Hig...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...